{"organizations": [], "uuid": "40e71c9a27f7381109f6987c93d35fa52ee33fa2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-anthera-pharmas-board-approves-per/brief-anthera-pharmas-board-approves-personnel-reorganization-plan-idUSFWN1RT0VN", "country": "US", "domain_rank": 408, "title": "BRIEF-Anthera Pharma's Board Approves Personnel Reorganization Plan", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-17T00:37:00.000+03:00", "replies_count": 0, "uuid": "40e71c9a27f7381109f6987c93d35fa52ee33fa2"}, "author": "", "url": "https://www.reuters.com/article/brief-anthera-pharmas-board-approves-per/brief-anthera-pharmas-board-approves-personnel-reorganization-plan-idUSFWN1RT0VN", "ord_in_thread": 0, "title": "BRIEF-Anthera Pharma's Board Approves Personnel Reorganization Plan", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-anthera pharma", "sentiment": "negative"}, {"name": "brief-anthera pharma's board approves personnel re", "sentiment": "neutral"}, {"name": "anthera pharmaceuticals", "sentiment": "none"}, {"name": "anthera pharmaceuticals inc - co", "sentiment": "none"}, {"name": "anthera pharmaceuticals inc", "sentiment": "none"}, {"name": "anthera pharmaceuticals inc - board", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 16 (Reuters) - Anthera Pharmaceuticals Inc:\n* ANTHERA PHARMACEUTICALS INC - BOARD APPROVED & COMMENCED A MANAGEMENT & ADMINISTRATIVE PERSONNEL REORGANIZATION PLAN\n* ANTHERA PHARMACEUTICALS - PLANS TO ELIMINATE NON-ESSENTIAL SALARIED POSITIONS, WITH MAJORITY OF ELIMINATIONS OCCURRING BETWEEN APRIL 15 & APRIL 30, 2018\n* ANTHERA PHARMACEUTICALS INC - CO EXPECTS TO RECORD EXIT CHARGES, IN FORM OF TERMINATION BENEFITS OF ABOUT $1.2 MILLION\n* ANTHERA PHARMACEUTICALS - DECIDED TO ELIMINATE POSITIONS OF CHIEF MEDICAL OFFICER, & SENIOR VP, MANUFACTURING & POSITION OF SENIOR VP, MEDICAL SCIENCES Source text ( bit.ly/2H8AbIg ) Further company coverage:\n ", "external_links": [], "published": "2018-04-17T00:37:00.000+03:00", "crawled": "2018-04-17T01:03:33.006+03:00", "highlightTitle": ""}